625098-83-1

Basic information

• Product Name: (1S,4R)-1-amino-4-benzyloxycarbonyl-cyclopent-2-ene hydrochloride
• Synonyms: (1S,4R)-1-amino-4-benzyloxycarbonyl-cyclopent-2-ene hydrochloride
• CAS NO: 625098-83-1
• Molecular Weight: 253.729
• Mol File: 625098-83-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (1S,4R)-1-amino-4-benzyloxycarbonyl-cyclopent-2-ene hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,4R)-1-amino-4-benzyloxycarbonyl-cyclopent-2-ene hydrochloride(625098-83-1)
• EPA Substance Registry System: (1S,4R)-1-amino-4-benzyloxycarbonyl-cyclopent-2-ene hydrochloride(625098-83-1)

Safety Data

• Hazardous Substances Data: 625098-83-1(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 151907-80-1 (1R,4S)-4-[(tert-butoxycarbonyl)amino]cyclopent-2-ene-1-carboxylic acid 
• 862120-91-0 C₁₈H₂₃NO₄ 
• 134003-04-6 (1R,4S)-4-aminocyclopenten-2-ene-1-carboxylic acid 

Downstream Products

• 625098-85-3 C₂₃H₂₈F₃NO₄ 
• 862120-89-6 C₁₉H₂₅NO₃ 

Relevant articles and documents

AMINOCYCLOPENTYL PYRIDOPYRAZINONE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

Compounds of Formula I and Formula II (wherein A, E, j, k, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R15, R16, R17, R18, R19, R24, R25, R26, R27, R28, R29, R30, R31, R32, R33, R34, X, Y and Z are as defined herein) which are modulators of chemokine receptor activity and are useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.

AMINOCYCLOPENTYL FUSED HETEROTRICYLICAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of formulae (I and II) (wherein A, D, E. X, l, m, n and R through R are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modul